✦ LIBER ✦

Postmortem blood tests for HIV, HBV, and HCV in a body donation program

✍ Scribed by Brian P. Watkins; Roger E. Haushalter; David L. Bolender; Stanley Kaplan; Gary L. Kolesari

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 60 KB
Volume: 11
Category: Article
ISSN: 0897-3806
DOI: 10.1002/(sici)1098-2353(1998)11:4<250::aid-ca5>3.0.co;2-v

No coin nor oath required. For personal study only.

✦ Synopsis

A retrospective analysis of the results of blood tests conducted on body donors received by the Anatomical Gift Registry of the Medical College of Wisconsin (MCW) was performed. Over the 5-year period from April 1992 through March 1997 a total of 785 body donors were tested for Human Immunodeficiency Virus (HIV) and Hepatitis B and C Viruses (HBV and HCV). Eighteen of the 785 donors (2.3%) tested positive for one of these infectious agents. Two donors were positive for HIV, six were positive for HBV and ten were positive for HCV. The death certificates and files of those donors who tested positive were reviewed and the results are presented here. Blood testing prior to the use of the body donors is an effective and reasonable way of identifying the presence of these infectious agents, thus reducing the risk to those who work with cadavers. The cost for the testing at MCW is about $60 per donor. Clin.

📜 SIMILAR VOLUMES

Surveillance of the genetic variation in

Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: Implications for blood safety, diagnostics, treatment, and molecular epidemiology

✍ Eric Delwart; Mary C. Kuhns; Michael P. Busch 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Surveillance for molecular variants in blood donors is vital to assuring that blood screening and supplemental assays are sensitive to circulating strains of blood-borne viruses. Blood screening and diagnostic assays licensed in the United States are largely based on prototype viral strains. Documen

A sensitive PCR method for detecting HCV

A sensitive PCR method for detecting HCV RNA in plasma pools, blood products, and single donations

✍ J. Saldanha; P. Minor 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 543 KB

## Abstract Although current manufacturing processes appear to efficiently inactivate hepatitis C virus (HCV), it is possible that contaminated blood products may result from failure of some stage during manufacture or from virus overload of plasma pools used for preparation of products. While anti